Rheumatoid arthritis, cognitive impairment, and neuroimaging biomarkers: results from the Mayo Clinic Study of Aging

Manuscript Number: 

22-0368R1

Author(s): 
Cynthia S. Crowson, John M. Davis III, Stephanie Q. Duong, David T. Jones, Michelle M. Mielke, Elena Myasoedova, Aivi Nguyen, Maria Vassilaki, Prashanthi Vemuri

Disclosures

Cynthia S. Crowson

  • Nothing to Disclose

John M. Davis III

  • Patents/Royalties
    Patent pending for a metabolic biomarker of disease activity in rheumatoid arthritis
    Grants
    • Agency: 
      Pfizer
      Dates: 
      2017-2022

Stephanie Q. Duong

  • Nothing to Disclose

David T. Jones

  • Nothing to Disclose

Michelle M. Mielke

  • Consulting Fees:
    I have received consulting fees from Biogen, LabCorp, Lilly and Merck

Elena Myasoedova

  • Nothing to Disclose

Aivi Nguyen

  • Nothing to Disclose

Maria Vassilaki

  • Consulting Fees:
    Consulting for F. Hoffmann-La Roche on analysis of data and interpretation (2021-2022) and have received a total of $6125; payments are submitted to my institution. No additional consulting fees are expected; continue collaboration until analysis/interpretation is complete.
    Equity:
    Equity ownership in Abbott Laboratories, Johnson and Johnson, Medtronic, AbbVie, and Amgen
    Grants
    • Agency: 
      F. Hoffmann-La Roche
      Dates: 
      07/01/2016-05/31/2020
    • Agency: 
      Biogen
      Dates: 
      12/01/2017 -9/29/2020

Prashanthi Vemuri

  • Lecture Fees:
    Miller Medical Communications Inc.